These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1330 related items for PubMed ID: 19497037

  • 1. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV, Christiaans MH, van den Berg-Loonen EM.
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Sep; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 4. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 5. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [Abstract] [Full Text] [Related]

  • 6. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 7. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Elola-Olaso AM, Calleja-Antolin SM, Romo E, Morales P, Moreno E, Paz-Artal E.
    Liver Transpl; 2008 Apr 20; 14(4):554-62. PubMed ID: 18383092
    [Abstract] [Full Text] [Related]

  • 8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 9. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC.
    Nephrol Dial Transplant; 2006 Sep 27; 21(9):2625-9. PubMed ID: 16644776
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 27; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 11. Luminex donor-specific crossmatches.
    Billen EV, Voorter CE, Christiaans MH, van den Berg-Loonen EM.
    Tissue Antigens; 2008 Jun 27; 71(6):507-13. PubMed ID: 18380779
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML, Smith JD.
    Hum Immunol; 2009 Aug 27; 70(8):605-9. PubMed ID: 19375471
    [Abstract] [Full Text] [Related]

  • 13. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S, Hourmant M, Valentin N, Paitier C, Giral-Classe M, Curry S, Follea G, Soulillou JP, Bignon JD.
    Transplantation; 2003 Feb 27; 75(4):477-82. PubMed ID: 12605113
    [Abstract] [Full Text] [Related]

  • 14. Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches.
    Huh KH, Kim MS, Kim HJ, Joo DJ, Kim BS, Ju MK, Kim SI, Kim YS.
    Transpl Int; 2012 Nov 27; 25(11):1131-7. PubMed ID: 22897830
    [Abstract] [Full Text] [Related]

  • 15. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI, Christiaans MH, Voorter CE, van Hooff HP, van den Berg-Loonen EM.
    Transplantation; 2006 Nov 15; 82(9):1142-7. PubMed ID: 17102764
    [Abstract] [Full Text] [Related]

  • 16. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 17. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 Jul 27; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 18. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 27; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N.
    Clin Transpl; 2011 Aug 27; ():223-35. PubMed ID: 22755416
    [Abstract] [Full Text] [Related]

  • 20. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.